about
Expression of calreticulin is associated with infiltration of T-cells in stage IIIB colon cancerIs the Antitumor Property of Trypanosoma cruzi Infection Mediated by Its Calreticulin?Chimeric Antigen Receptor-Modified T Cells for Solid Tumors: Challenges and ProspectsLocal tumour hyperthermia as immunotherapy for metastatic cancer.Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advancesRadiation for Awakening the Dormant Immune System, a Promising Challenge to be ExploredImmune microenvironment in colorectal cancer: a new hallmark to change old paradigmsOncolytic viruses as anticancer vaccinesChemotherapeutic agents in noncytotoxic concentrations increase antigen presentation by dendritic cells via an IL-12-dependent mechanismImmunological factors relating to the antitumor effect of temozolomide chemoimmunotherapy in a murine glioma model.Intensive chemotherapy for acute myeloid leukemia differentially affects circulating TC1, TH1, TH17 and TREG cells.Immunogenic and tolerogenic cell death.Identification of the rheumatoid arthritis shared epitope binding site on calreticulin.Calreticulin: non-endoplasmic reticulum functions in physiology and disease.Identification of Differentially Expressed Proteins in Liver in Response to Subacute Ruminal Acidosis (SARA) Induced by High-concentrate Diet.A role for calreticulin in the pathogenesis of rheumatoid arthritis.Is it all That Bad When Living with an Intracellular Protozoan? The Role of Trypanosoma cruzi Calreticulin in Angiogenesis and Tumor Growth.Comparative proteomic analysis of the hepatic response to heat stress in Muscovy and Pekin ducks: insight into thermal tolerance related to energy metabolismComparative proteomic and bioinformatic analysis of the effects of a high-grain diet on the hepatic metabolism in lactating dairy goats.Effects of cytarabine on activation of human T cells - cytarabine has concentration-dependent effects that are modulated both by valproic acid and all-trans retinoic acidA new role for the P2X7 receptor: a scavenger receptor for bacteria and apoptotic cells in the absence of serum and extracellular ATPReticulon Protein-1C: A New Hope in the Treatment of Different Neuronal Diseases.Arginylated calreticulin at plasma membrane increases susceptibility of cells to apoptosis.Loss-of-function alleles of P2RX7 and TLR4 fail to affect the response to chemotherapy in non-small cell lung cancer.CD47 blockade triggers T cell-mediated destruction of immunogenic tumors.Morphometric analysis of immunoselection against hyperploid cancer cellsThe anticancer immune response: indispensable for therapeutic success?The oncolytic peptide LTX-315 triggers immunogenic cell death.New insights into the role of the immune microenvironment in breast carcinoma.Tumor necrosis factor is dispensable for the success of immunogenic anticancer chemotherapy.Inhibition of formyl peptide receptor 1 reduces the efficacy of anticancer chemotherapy against carcinogen-induced breast cancer.Calreticulin expression: Interaction with the immune infiltrate and impact on survival in patients with ovarian and non-small cell lung cancer.Dendritic cells: a critical player in cancer therapy?The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapiesCombination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer.Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling.iNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cells.Reprogramming antitumor immunity against chemoresistant ovarian cancer by a CXCR4 antagonist-armed viral oncotherapy.Is CD47 an innate immune checkpoint for tumor evasion?How to improve the immunogenicity of chemotherapy and radiotherapy.
P2860
Q24609433-2B52FDA7-8E2F-48C1-B852-DA9E49401607Q26741412-F504602A-3FFC-42BB-99A0-C7AF61D30E1DQ26753082-C1353455-D654-4738-A580-5F0DF4521DBBQ26823968-2EAD1C86-B07A-4B6D-BFFC-B77E190D107FQ26863779-43DB2514-41F2-4AD1-8B06-4858124E9457Q26865395-B28924F9-B9B8-41FB-B9D2-2B8426CF37CBQ27008654-7AEBC5B4-88FE-43E9-AE84-FDBCD01F81E6Q27025600-CC2A61D7-44E2-4F2E-BE01-3BD8F7D66834Q28384980-A437E9BA-ABB2-4642-99F0-0915C5733E41Q33613430-1617CC3B-EFB2-484D-BB80-1302FAF3AFE5Q33629475-AB50ABE7-6552-45C0-B0C3-CEDD0D94F463Q33639097-7E7D9C60-CEC4-45A1-9197-029BD3C3FF64Q33641510-0BEAAAFF-8CF3-47CA-95E7-D5119AA518EEQ33694634-7417E254-F750-490A-ADEC-F49CF119C998Q33945512-6A25798D-9CB5-42B8-8DCF-CEC6FB6E8733Q34222660-9CF6A4A6-9A40-4842-B08C-F6C24322DB1BQ34933283-A718A125-E738-475E-AD7A-23AA31FD0EE4Q35014970-36E85337-8FB9-4C4E-BB5B-ED4290DAC822Q35049198-B34A3400-56D3-47C7-8F27-8C03CFE88E2CQ35575464-3A80EBF1-0FA2-400A-B076-8E0D94BD8D96Q35987687-E50CCF5C-7D6E-4D77-A114-4235AF9FC319Q36010989-316E4E37-1CB1-4EFD-B7D1-F80F63620A5DQ36052477-77F05EF1-E9B6-406D-8D17-7601FC1BB4A7Q36057423-C02D0DC9-906B-445C-87A4-5674E2FD1B1BQ36137576-3D1E09B5-6B7C-4EAD-9234-4897E8D3EF2CQ36562331-24E961E7-6790-4977-8886-90C8CB7213A6Q36677608-3F09DF83-441A-401F-B1D2-D8ACF2A34962Q36774984-0C1DA197-6834-408B-B0CE-E351C3B19949Q36938731-D13086D8-48ED-4B43-B677-DC559D714723Q37028031-15DEE165-10CE-4667-8208-F5AA39673EBEQ37079087-9F377AE5-9EBD-4FCA-AFE7-A48B73BD0357Q37222093-06680ADE-8139-4BC5-9B66-7119BDAAE886Q37276138-EB833A63-6472-453E-976A-4EDB77A7D76DQ37285838-402A6175-506A-42D7-AF27-A3083D031D30Q37299843-8CC35A2A-2A0D-4DDA-B1D6-ACA102A81BF0Q37379390-0CF064E2-9D05-4216-B911-C37F226A479BQ37448441-16CD5D8D-C29F-4812-9A15-41516D9BE012Q37502464-4EC1C134-2E13-4C8E-A64F-B8A88AC25DE7Q37579038-D2986239-7B42-4F8B-8B91-180F89B5E23CQ37836489-DCF3561B-FFE1-486C-A1E6-3EB41552FBC2
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Ecto-calreticulin in immunogenic chemotherapy.
@en
type
label
Ecto-calreticulin in immunogenic chemotherapy.
@en
prefLabel
Ecto-calreticulin in immunogenic chemotherapy.
@en
P2093
P50
P1476
Ecto-calreticulin in immunogenic chemotherapy.
@en
P2093
Michel Obeid
Roberta Tufi
Theocharis Panaretakis
P356
10.1111/J.1600-065X.2007.00567.X
P50
P577
2007-12-01T00:00:00Z